Welcome! The spring has sprung and we are here to round up the major class action opinions and settlements finalized during the first quarter of 2018. It was another active quarter with significant activity across all the areas we monitor. We continue to see the effects of the U.S. Supreme Court’s Bristol-Myers Squibb decision, with several opinions citing the case when dismissing class members due to jurisdictional issues.
Please see full publication below for more information.